Exchange Traded Concepts’s ADMA Biologics ADMA Stock Holding History

Exchange Traded Concepts’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.2K	Sell	3,371 -126	-4%	-$1.15K	﹤0.01%	1541
2026 Q1	$31.5K	Sell	3,497 -1,123	-24%	-$17.7K	﹤0.01%	1469
2025 Q4	$84.3K	Buy	4,620 +168	+4%	+$2.83K	﹤0.01%	1406
2025 Q3	$65.3K	Buy	+4,452	New	+$76.3K	﹤0.01%	1287

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Exchange Traded Concepts's ADMA Position: Q2 2026 in Review

Exchange Traded Concepts reduced its ADMA Biologics (ADMA) stake by 3.6% in Q2 2026, selling an estimated $1.15K and leaving 3,371 shares worth $28.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

Exchange Traded Concepts first reported a position in ADMA in Q3 2025 and has held it in 4 quarters since. The position peaked at $84.3K in Q4 2025. 62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Exchange Traded Concepts held 3,371 shares of ADMA Biologics worth $28.2K as of Q2 2026.
Exchange Traded Concepts sold 126 ADMA Biologics shares in Q2 2026, an estimated $1.15K.
ADMA Biologics made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1541 holding.
Exchange Traded Concepts first reported a position in ADMA Biologics in Q3 2025 and has held it in 4 quarters since.
Exchange Traded Concepts's ADMA Biologics position peaked at $84.3K in Q4 2025.
62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.